Clinical Trials Browser

Breast Neoplasms, Colonic Neoplasms, Lymphoma, Multiple Myeloma, Neoplasms, Radiation Injuries, Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Cardiotoxicity

NCT06881940 2025-03-18

CARPTOX-BC

Phase NA Not yet recruiting

284 enrolled

Breast

Breast Neoplasms, Cardiotoxicity

NCT05465031 2025-03-14

Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINSTREAM)

Phase 4 Recruiting

600 enrolled

Breast

Breast Diseases, Breast Neoplasms, Heart Failure, Neoplasms, Second Primary, Cardiotoxicity

NCT05781672 2025-02-19

SpeckleAnthra2

Phase NA Terminated

134 enrolled

Neoplasms, Cardiotoxicity

NCT05403736 2025-02-06

CARMA

Phase NA Completed

20 enrolled

BreastGastrointestinalThoracic

Breast Neoplasms, Esophageal Neoplasms, Lung Neoplasms, Neoplasms, Cardiotoxicity

NCT05699915 2025-01-30

CAVACI

Phase NA Terminated

105 enrolled

Myocarditis, Neoplasms, Atherosclerosis, Cardiotoxicity

NCT03934905 2024-11-20

Protective Effects of the Nutritional Supplement Sulforaphane on Doxorubicin-Associated Cardiac Dysfunction

Phase 1/2 Recruiting

70 enrolled

Cardiotoxicity

NCT06684509 2024-11-12

Atorvaststin and Cardiotoxicity in Acute Myloid Leukemia

Phase 1/2 Not yet recruiting

46 enrolled

LymphoidOther hematologic neoplasm

Hodgkin Disease, Leukemia, Cardiotoxicity

NCT05703126 2024-11-05

Clinical and Diagnostic Significance of Endothelial Dysfunction and Myocardial Contractility in Patients With AML

Phase NA Recruiting

100 enrolled

Other hematologic neoplasm

Leukemia, Myeloid, Acute, Cardiotoxicity

NCT04486573 2024-10-22

Cardiac Effects From Radiation Therapy by MRI

Phase NA Completed

6 enrolled

Neoplasms, Cardiotoxicity

NCT06622954 2024-10-02

PROTECT-COR

Phase NA Recruiting

32 enrolled

Breast

Breast Neoplasms, Cardiotoxicity

NCT06595316 2024-09-19

Exercise for Ameliorating Chemotherapy Cardiotoxicity

Phase NA Not yet recruiting

30 enrolled

Breast

Breast Neoplasms, Motor Activity, Cardiotoxicity

NCT03748550 2024-08-21

EXACT2

Phase NA Active not recruiting

7 enrolled

Breast

Breast Neoplasms, Cardiovascular Diseases, Cardiotoxicity

NCT03486340 2024-07-08

CATCH

Phase NA Completed

218 enrolled

Chest Pain, Acute Coronary Syndrome, Cardiotoxicity

NCT04939883 2024-06-28

CardioTox

Phase 4 Unknown

1,018 enrolled

Neoplasms, Cardiotoxicity

NCT05467111 2024-04-11

CardioProtEx

Phase NA Unknown

40 enrolled

Breast

Breast Neoplasms, Motor Activity, Cardiotoxicity

NCT06341842 2024-04-02

PROTECT

Phase 2 Unknown

316 enrolled

Breast

Breast Neoplasms, Cardiotoxicity

Clinical Trials

A Study of Blood Pressure Control During Cancer Treatment

HER2HEART-US: Prevention of Cardiotoxicity in Breast Cancer Patients Receiving HER2-directed Therapy

SPARTACUS

CMR-Onko

STOP-MED CTRCD

BREATHS

PULSE

CARE-BREAST

Hyperpolarized Carbon 13-Based Metabolic Imaging to Detect Radiation-Induced Cardiotoxicity

Evaluating 6-months of HER2-targeted Therapy in Patients With HER2 Positive Early-stage Breast Cancer That Achieve a Pathological Complete Response to Neoadjuvant Systemic Therapy

BE-FITTER

HO170DLBCL

OTT 15-05

ROSUBREAST

HIMALAYAS-P

HIMALAYAS

EMPACT

ATOPE

Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted

CCTGuide Pilot

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

DAPA-AIC

Evaluation of Possible Safety and Efficacy of Fenofibrate in the Prophylaxis of Doxorubicin Induced Cardiotoxicity in Breast Cancer Patients

DETECT

PROACT

NTproBNP-Guide

Exercise Preconditioning in Ovarian Cancer

The Effects of Two Exercise Interventions on Breast Cancer Patients Undergoing Cardiotoxic Chemotherapies

TRUST-ACE

CorTox

JUSTIFY

HER2BIC

Effect of Anthracyclines and Cyclophosphamide on Cardiovascular Responses

CARTIER

CARPTOX-BC

Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINSTREAM)

SpeckleAnthra2

CARMA

CAVACI

Protective Effects of the Nutritional Supplement Sulforaphane on Doxorubicin-Associated Cardiac Dysfunction

Atorvaststin and Cardiotoxicity in Acute Myloid Leukemia

Clinical and Diagnostic Significance of Endothelial Dysfunction and Myocardial Contractility in Patients With AML

Cardiac Effects From Radiation Therapy by MRI

PROTECT-COR

Exercise for Ameliorating Chemotherapy Cardiotoxicity

EXACT2

CATCH

CardioTox

CardioProtEx

PROTECT